CYP2C9 and ABCG2 polymorphisms as risk factors for developing adverse drug reactions in renal transplant patients taking fluvastatin: a case–control study

Pharmacogenomics , September 2013, Vol. 14, No. 12, Pages 1419-1431.
Source: Future Medicine: Pharmacogenomics - Category: Genetics & Stem Cells Tags: article Source Type: research